BRIEF-Angitia Biopharmaceuticals Announces $130 Million Series D Financing
Reuters
Feb 05
BRIEF-Angitia Biopharmaceuticals Announces $130 Million Series D Financing
Feb 5 (Reuters) - BlackRock Inc BLK.N:
ANGITIA BIOPHARMACEUTICALS ANNOUNCES $130 MILLION SERIES D FINANCING
ANGITIA BIOPHARMACEUTICALS - FINANCING CO-LED BY FRAZIER LIFE SCIENCES AND VENROCK HEALTHCARE CAPITAL PARTNERS
ANGITIA BIOPHARMACEUTICALS - ROUND WITH PARTICIPATION FROM ASCENTA CAPITAL, CERTAIN FUNDS AND ACCOUNTS MANAGED BY BLACKROCK, BVF PARTNERS
ANGITIA BIOPHARMACEUTICALS - KEVIN LI, M.D., FROM FRAZIER LIFE SCIENCES WILL JOIN BOARD
Source text: ID:nGNX13wLmG
Further company coverage: BLK.N
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.